ArticleHeliyon2024

Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in Spring 2023.

Martynas Simanavičius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.